Document is current
Any future updates will be listed below
-
Authors
Takada, Masahiro https://orcid.org/0000-0002-5954-1296
Yoshimura, Michio
Kotake, Takeshi
Kawaguchi, Kosuke
Uozumi, Ryuji
Kataoka, Masako
Kato, Hironori
Yoshibayashi, Hiroshi
Suwa, Hirofumi
Tsuji, Wakako
Yamashiro, Hiroyasu
Suzuki, Eiji
Torii, Masae
Yamada, Yosuke
Kataoka, Tatsuki
Ishiguro, Hiroshi
Morita, Satoshi
Toi, Masakazu
- License Information
-
More Information
Article History
Received: 11 March 2022
Accepted: 23 December 2022
First Online: 27 December 2022
Competing interests
: MTa received research grants from the Kyoto Breast Cancer Research Network (KBCRN), Daiichi Sankyo, Yakult, AstraZeneca, Japan Breast Cancer Research Group (JBCRG), and Medbis. MTa received honoraria from Chugai, Eisai, AstraZeneca, Eli Lily, Daiichi Sankyo, Nippon Kayaku, Pfizer, and Mitaka Kohki. KK received research support from Eli Lily, TELUMO, and KBCRN. KK received a speaking fee from Chugai Pharmaceutical and Eisai. RU received consulting fees from Eisai, Sawai Pharmaceutical, and EP Croit, outside this work. HY received honoraria from Chugai, Daiichi-Sankyo, Pfizer, Kyowa Kirin, Eisai, Eli Lilly, Takeda, and Taiho. SM received honoraria from AstraZeneca K.K., Bristol-Myers Squibb Company, Chugai Pharmaceutical Co. Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., MSD K.K., Pfizer Japan Inc., Ono Pharmaceutical Co. Ltd., and Taiho Pharmaceutical Co. Ltd. SM received research funding (institution) from Eisai Co., Ltd. MTo received research grants from Chugai, Takeda, Pfizer, Kyowa-Kirin, Taiho, JBCRG assoc., Eisai, Eli Lilly, Daiichi-Sankyo, AstraZeneca, Astellas, Shimadzu, Yakult, Nippon Kayaku, AFI technology, Luxonus, Shionogi, GL Science. MTo received lecture honoraria from Chugai, Takeda, Pfizer, Kyowa-Kirin, Taiho, Eisai, Daiichi-Sankyo, AstraZeneca, Eli Lilly, MSD, Exact Science, Novartis, Konica Minolta, Shimadzu, Yakult, Nippon Kayaku. MTo is a member of the advisory board of Kyowa-Kirin, Daiichi-Sankyo, Eli Lilly, Konica Minolta, BMS, Athenex Oncology, Bertis, Terumo, Kansai Medical Net. MTo is also a member of the board of directors (no salary) of KBCRN, JBCRN, and Organisation for Oncology and Translational Research (OOTR). All remaining authors declare no conflicts of interest.
